BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusion clinical trials

HOVON 146 ALL: Blinatumomab added to prephase and consolidation therapy in precursor B-acute lymphoblastic leukemia in adults. A phase II trial.

This study looks at a new way to treat a type of blood cancer called B-cell acute lymphoblastic leukaemia in adults. It's testing if adding a drug called Blincyto to standard treatment can help more patients get rid of tiny amounts of cancer cells after treatment.